Organ Preservation Market—Forecast till 2027

Organ Preservation Market—Forecast till 2027

Organ Preservation Market—Forecast till 2027

Market Overview

As per the MRFR analysis, the global organ preservation market is anticipated to witness a healthy market expansion of 6.48% during the review period to surpass USD 304.68 million by the end of 2027.

Organ preservation is the stock line for organ transplantation. At present, the pancreas, liver, and kidney can be safeguarded for as long as two days by flushing the organs with the University of Wisconsin (UW) organ preservation arrangement as well as putting away them at hypothermia (0-5 degrees C). The UW arrangement is viable in the light of the fact that it utilized a few cell impermeant specialists like raffinose, lactobionic corrosive, and hydroxyethyl starch which decrease the phones from aggravation during cold ischemic stockpiling. The rising number of organ relocation techniques goes about as a significant driver in the worldwide organ preservation market from 2021 to 2027. In any case, the significant expense related to organ transplantation hampers the development of the organ preservation market during the gauge time frame. Expanding government drives connected with organ transfers and organ gifts are supposed to set out freedom in the worldwide organ preservation market.

Segment Overview

The global organ preservation market is categorized among solution, preservation techniques, organ type, and end-user.

The Solution segment is further classified into the University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, and Citrate Solution.

The preservation techniques segment is divided into static cold storage and dynamic cold storage. Dynamic cold storage is further divided into hypothermic machine perfusion, normothermic machine perfusion, and oxygen per sufflation.

Based on the organ type, the market is divided into heart, kidney, lungs, liver, and others. The end-user segment divides the market into organ banks, hospitals & clinics, and others.

Regional Analysis

The Americas is likely to lead the global organ preservation market owing to the largest market share of 45.7% during the review period. The regional market growth is attributed to the growing number of organ transplant procedures, growing incidences of multiple organ failure, and rising geriatric failure. Americas is classified into North America and Latin America. The North American market is spread across the US and Canada.

Europe is the second-biggest market and holds a solid offer in the worldwide organ protection market. The European market is supposed to develop at a tough rate during the conjecture time frame because of cutting-edge treatment offices and rising instances of greasy liver sickness.

Asia-Pacific is assessed to be the quickest developing business sector attributable to the creation of medical care foundations and expanding extra cash in agricultural nations like China and India. The Middle East and Africa is supposed to observe consistent development because of an absence of mindfulness with respect to organ gift, restricted admittance, and the exorbitance of treatment offices among the populace.

Major Players

The prominent players operating in the global organ preservation are TransMedics Group, Inc (US), Inc (US), Shanghai Genext Medical Technology Co., Ltd (China), 21st Century Medicine (US), Bristol Myers Squibb (US), Artivion, Inc (US), BioLife Solutions, Paragonix Technologies Inc (US), Xvivo Perfusion AB (US), Accord Healthcare Limited (UK), Franz Köhler Chemie GmbH (Germany), and Waters Medical Systems (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Companies Mentioned

TransMedics Group
Inc (US)
Inc (US)
Shanghai Genext Medical Technology Co. Ltd (China)
21st Century Medicine (US)
Bristol Myers Squibb (US)
Artivion
Inc (US)
BioLife Solutions
Paragonix Technologies Inc (US)
Xvivo Perfusion AB (US)
Accord Healthcare Limited (UK)
Franz Köhler Chemie GmbH (Germany)
and Waters Medical Systems (US)